image
Cassava Sciences, Inc. SAVA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 26.91
2.95 %
$ 1.29 B
Market Cap
-19.5
P/E
BALANCE SHEET
152 M ASSETS
-35.42%
Growth Rates
1Year -35.42%
3Years 17.16%
5Years 49.75%
7Years 34.24%
10Years 11.71%
14.2 M LIABILITIES
94.59%
Growth Rates
1Year 94.59%
3Years 89.08%
5Years 94.42%
7Years 54.85%
10Years 22.93%
137 M EQUITY
-39.58%
Growth Rates
1Year -39.58%
3Years 14.24%
5Years 47.59%
7Years 33.04%
10Years 11.03%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Cassava Sciences, Inc.
image
Current Assets 130 M
Cash & Short-Term Investments 121 M
Receivables 962 K
Other Current Assets 7.54 M
Non-Current Assets 22 M
Long-Term Investments 0
PP&E 21.9 M
Other Non-Current Assets 176 K
Current Liabilities 14.2 M
Accounts Payable 10.6 M
Short-Term Debt 0
Other Current Liabilities 3.62 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999
ASSETS
Cash & Cash Equivalents 121.1 201.0 233.4 93.5 23.1 19.8 10.5 18.7 31.3 40.6 49.8 56.3 73.1 4.8 35.8 153.2 86.6 16.4 95.7 1.4 12.0 50.1 65.3 78.9 9.3
Short Term Investments 0 0 0 0 0 0 0 2.1 0 0 1.2 6.9 25.0 86.4 140.0 36.9 118.5 188.0 117.0 98.0 65.4 0 0 0 0
Receivables 1.0 0 0 0 0 0 0 0 0 0 0 0 0 7.1 0 0 0 0 0.9 0 0 55 K 0.1 0.4 15.4 K
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 7.5 11.1 11.0 0.9 0.3 0.2 0.2 0.4 0.4 0.2 0.3 0.3 0.4 0.1 2.7 0.5 0.3 2.7 0.6 0.3 1.3 1.1 0.3 0.4 41.4 K
Total Current Assets 129.6 211.2 244.5 94.0 23.3 20.0 10.7 19.1 31.7 40.8 50.1 56.5 98.5 98.5 178.5 190.6 205.4 207.1 214.2 99.7 78.8 51.2 65.7 79.8 9.4
PP&E 21.9 23.0 20.8 0.3 0.1 100 K 0.2 0.3 0.2 100 K 0 0 0.1 0.3 0.5 0.8 1.6 1.3 1.6 1.5 1.7 2.0 2.3 1.3 44.8 K
Intangible Assets 0.2 0.6 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0.4 0 0 1 K 32 K 68 K 27 K 23 K 0 0.4 0.4 0.4 3.0 2.0 0.6 75 K 75 K 75 K 75 K 75 K 75 K 75 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 151.7 234.8 266.8 94.3 23.5 20.1 10.8 19.3 31.9 40.9 50.1 56.9 99.0 99.2 182.0 193.4 207.6 208.5 215.8 101.2 80.5 53.3 68.1 81.1 9.4
LIABILITIES
Accounts Payable 10.6 4.0 7.1 0.9 0.5 0.3 0.4 0.3 1.0 0.2 0.4 0.4 0.5 1.1 1.3 2.2 3.6 1.0 1.0 0.9 3.4 2.6 2.2 2.3 0.3
Short Term Debt 0 0.2 0.2 0.1 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 3.6 2.8 5.2 0.8 0.8 0.2 0.7 0.4 1.5 0.7 1.4 1.8 1.9 2.1 2.8 3.5 2.7 6.7 5.1 6.9 0 0 0.3 0.1 0
Total Current Liabilities 14.2 7.1 12.5 1.9 1.4 0.5 1.1 0.7 2.6 0.8 1.8 10.0 13.3 14.1 18.5 20.1 20.7 36.7 32.3 7.8 4.0 3.1 2.5 2.5 0.3
Long Term Debt 0 70 K 0.3 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 26 K 0 0 0 0 0 0 0 0 0 0.4 0.4 0.4 1.4 0.9 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0.2 55 K (0.2) 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0
Total Liabilities 14.2 7.3 12.9 2.1 1.4 0.5 1.1 0.7 2.6 0.8 1.8 43.7 54.6 66.3 73.8 89.2 103.7 130.5 152.4 7.8 4.0 3.1 2.5 2.5 0.3
EQUITY
Common Stock 42 K 511.1 461.2 267.1 190.7 17 K 7 K 46 K 46 K 46 K 45 K 45 K 45 K 43 K 42 K 42 K 44 K 44 K 44 K 44 K 35 K 27 K 26.8 K 26.7 K 9.44 K
Retained Earnings (380.8) (283.6) (207.3) (174.9) (168.6) (164.0) (157.4) (145.5) (130.6) (116.5) (104.1) (135.7) (132.2) (129.6) (117.6) (114.1) (118.1) (136.5) (142.7) (112.0) (74.2) (52.6) (36.7) (22.4) (4.9)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 (0.9) (0.8) (0.7) (0.7) 1 K 1 K 4 K 0.1 0.5 0.3 0.3 0.6 (0.4) (0.5) (0.5) 43 K (0.4) (1.9) (5.1) (5.1)
Total Equity 137.5 227.5 253.9 92.2 22.1 19.6 9.7 18.6 29.4 40.1 48.3 13.1 44.4 32.9 108.3 104.3 103.9 77.9 63.4 93.4 76.6 50.2 65.6 78.7 9.1
Total Liabilities and Equity 151.7 234.8 266.8 94.3 23.5 20.1 10.8 19.3 31.9 40.9 50.1 56.9 99.0 99.2 182.0 193.4 207.6 208.5 215.8 101.2 80.5 53.3 68.1 81.1 9.4
SHARES OUTSTANDING
Common Shares Outstanding 41.9 40.2 39.4 26.1 17.4 10.7 6.5 6.5 6.5 6.5 6.4 6.4 6.3 6.1 6.0 6.0 6.3 6.3 6.3 5.3 4.2 3.9 3.6 1.9 0.5